GeneOne Life Science Inc (011000)

Currency in KRW
2,045
+126(+6.57%)
Closed·
Unusual trading volume
011000 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,9922,240
52 wk Range
1,6504,270
Key Statistics
Bid/Ask
2,040.00 / 2,045.00
Prev. Close
1,919
Open
2,000
Day's Range
1,992-2,240
52 wk Range
1,650-4,270
Volume
5.68M
Average Volume (3m)
719.02K
1-Year Change
-4.2155%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
011000 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Biotechnology industry

GeneOne Life Science Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

GeneOne Life Science Company Profile

GeneOne Life Science, Inc., a biopharmaceutical company, engages in the research, development, and contract manufacturing of nucleic acid-based biopharmaceuticals. Its small molecule pipeline comprises GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS-1200, which is Phase II clinical trial for treatment of COVID-19. The company’s nucleic acid vaccines include GLS-3000 mRNA under feasible study and GLS-5310 DNA under phase 2 stage for the treatment of SARS-CoV-2; GLS-5100 under pre-clinical stage for prevention of herpes zoster; and GLS-5140 under pre-clinical stage for the treatment of SFTS prophylaxis. In addition, it is developing GLS-5300, which is in Phase II clinical trial for MERS; GLS-5700 that is in Phase I clinical trial for Zika; and GLS-6150, which is in Phase I clinical trial for treatment of hepatitis C re-infection prophylaxis, as well as GLS-6100 that is in pre-clinical stage for hepatitis C prophylaxis. Further, the company’s discovery and optimization stage pipeline comprise GLS-7000 for the treatment of breast cancer; GLS-7100 for treating hemophilia A; GLS-8000 for the prevention of chronic hepatitis B; and GLS-8100 for treating rheumatoid arthritis. Additionally, it engages in the cGMP production of nucleic acid-based products, including DNA plasmids and mRNA. The company was formerly known as VGX International Inc. and changed its name to GeneOne Life Science, Inc. in April 2014. GeneOne Life Science, Inc. was founded in 1976 and is headquartered in Seoul, South Korea.

Compare 011000 to Peers and Sector

Metrics to compare
011000
Peers
Sector
Relationship
P/E Ratio
−3.4x−10.4x−0.6x
PEG Ratio
−0.110.020.00
Price/Book
3.1x2.1x2.6x
Price / LTM Sales
5.6x6.5x3.4x
Upside (Analyst Target)
-38.9%44.9%
Fair Value Upside
Unlock11.8%6.3%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 14, 2025
EPS / Forecast
-135.00 / --
Revenue / Forecast
5.08B / --
EPS Revisions
Last 90 days

People Also Watch

71,800
025540
-4.01%
59,400
103590
-11.34%
49,350
003570
-0.40%
24,200
007340
-3.78%
3,665
003620
-5.66%

FAQ

What Is the GeneOne Life Science (011000) Share Price Today?

The live GeneOne Life Science share price today is 2,045

What Stock Exchange Does GeneOne Life Science (011000) Trade On?

GeneOne Life Science is listed and trades on the Seoul Stock Exchange.

What Is the Ticker (Stock Symbol) for GeneOne Life Science?

The stock symbol (also called a 'ticker') for GeneOne Life Science is "011000."

What Is the Current GeneOne Life Science Market Cap?

As of today, GeneOne Life Science market capitalisation is 174.23B.

What Is GeneOne Life Science's (011000) Earnings Per Share (TTM)?

The GeneOne Life Science EPS is currently -627.50 (Trailing Twelve Months).

Is 011000 a Buy or Sell From a Technical Analyst Perspective?

Based on today's GeneOne Life Science moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has GeneOne Life Science Stock Split?

GeneOne Life Science has split 13 times. (See the 011000 stock split history page for full effective split date and price information.)

How Many Employees Does GeneOne Life Science Have?

GeneOne Life Science has 41 employees.

What is the current trading status of GeneOne Life Science (011000)?

As of 02 Feb 2026, GeneOne Life Science (011000) is trading at a price of 2,045, with a previous close of 1,919. The stock has fluctuated within a day range of 1,992 to 2,240, while its 52-week range spans from 1,650 to 4,270.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.